Corient Capital Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$482K Buy
5,708
+316
+6% +$26.7K 0.04% 347
2022
Q2
$455K Sell
5,392
-242
-4% -$20.4K 0.03% 367
2022
Q1
$494K Buy
5,634
+1,443
+34% +$127K 0.03% 392
2021
Q4
$366K Sell
4,191
-6,837
-62% -$597K 0.02% 454
2021
Q3
$902K Buy
11,028
+432
+4% +$35.3K 0.07% 229
2021
Q2
$967K Buy
10,596
+1,344
+15% +$123K 0.07% 219
2021
Q1
$791K Buy
9,252
+833
+10% +$71.2K 0.07% 229
2020
Q4
$795K Sell
8,419
-3,202
-28% -$302K 0.08% 203
2020
Q3
$1.01M Buy
11,621
+225
+2% +$19.6K 0.12% 162
2020
Q2
$995K Buy
11,396
+67
+0.6% +$5.85K 0.12% 157
2020
Q1
$934K Sell
11,329
-4,297
-27% -$354K 0.15% 130
2019
Q4
$1.48M Sell
15,626
-592
-4% -$56K 0.19% 123
2019
Q3
$1.41M Sell
16,218
-921
-5% -$80.1K 0.2% 125
2019
Q2
$1.57M Sell
17,139
-2,465
-13% -$225K 0.24% 108
2019
Q1
$1.69M Sell
19,604
-598
-3% -$51.5K 0.27% 106
2018
Q4
$1.55M Buy
20,202
+1,520
+8% +$117K 0.28% 106
2018
Q3
$1.44M Hold
18,682
0.24% 120
2018
Q2
$1.27M Buy
18,682
+2,301
+14% +$156K 0.22% 131
2018
Q1
$1.19M Buy
16,381
+4,535
+38% +$328K 0.22% 114
2017
Q4
$891K Sell
11,846
-876
-7% -$65.9K 0.15% 142
2017
Q3
$979K Sell
12,722
-233
-2% -$17.9K 0.19% 122
2017
Q2
$969K Buy
12,955
+334
+3% +$25K 0.15% 140
2017
Q1
$840K Buy
12,621
+2,030
+19% +$135K 0.13% 154
2016
Q4
$691K Sell
10,591
-1,493
-12% -$97.4K 0.12% 168
2016
Q3
$855K Buy
+12,084
New +$855K 0.16% 139